Performance of Noninvasive Liver Fibrosis Tests in Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease

被引:0
作者
Saleh A. Alqahtani
Pegah Golabi
James M. Paik
Brian Lam
Amir H. Moazez
Hazem A. Elariny
Zachary Goodman
Zobair M. Younossi
机构
[1] Center for Outcomes Research in Liver Diseases,Division of Gastroenterology and Hepatology
[2] Johns Hopkins University,Betty and Guy Beatty Center for Integrated Research
[3] King Faisal Specialist Hospital & Research Center,undefined
[4] Center For Liver Diseases,undefined
[5] Department of Medicine,undefined
[6] Inova Health System,undefined
来源
Obesity Surgery | 2021年 / 31卷
关键词
Fatty liver; Noninvasive test; Bariatric surgery; Outcome, NASH; Liver fibrosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2002 / 2010
页数:8
相关论文
共 173 条
[1]  
Loomba R(2013)The global NAFLD epidemic Nat Rev Gastroenterol Hepatol 10 686-690
[2]  
Sanyal AJ(2017)Clinical epidemiology and disease burden of nonalcoholic fatty liver disease World J Gastroenterol 23 8263-8276
[3]  
Perumpail BJ(2018)Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease Hepatology 67 123-133
[4]  
Khan MA(2018)Nonalcoholic fatty liver disease (NAFLD): Diagnosis, pitfalls, and staging Ann Diagn Pathol 37 83-90
[5]  
Yoo ER(2015)A multisystem disease J Hepatol 62 S47-S64
[6]  
Cholankeril G(2017)Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis Hepatology 65 1557-1565
[7]  
Kim D(2018)The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases Hepatology 67 328-357
[8]  
Ahmed A(2016)Fibrosis assessment in nonalcoholic fatty liver disease (NAFLD) in 2016 Dig Dis Sci 61 1356-1364
[9]  
Estes C(2018)Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis Hepatology 68 349-360
[10]  
Razavi H(2018)Non-invasive assessment of non-alcoholic fatty liver disease: clinical prediction rules and blood-based biomarkers J Hepatol 68 305-315